Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Jeffrey S Hoch, Jaclyn Beca, Mona Sabharwal, Scott W. Livingstone, Anthony L.A. Fields

Research output: Contribution to journalLetterpeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?'. Together they form a unique fingerprint.